These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3125211)

  • 1. Premature luteinization of follicles during ovarian stimulation for in-vitro fertilization.
    Hamori M; Stuckensen JA; Rumpf D; Kniewald T; Kniewald A; Kurz CS
    Hum Reprod; 1987 Nov; 2(8):639-43. PubMed ID: 3125211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete and partial luteinized unruptured follicle syndrome after ovarian stimulation with clomiphene citrate/human menopausal gonadotrophin/human chorionic gonadotrophin.
    Coetsier T; Dhont M
    Hum Reprod; 1996 Mar; 11(3):583-7. PubMed ID: 8671271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of gonadotrophin-releasing hormone agonists administered as desensitizing or flare protocols on hormonal function in the luteal phase of hyperstimulated cycles.
    Norman RJ; Warnes GM; Wang X; Kirby CA; Matthews CD
    Hum Reprod; 1991 Feb; 6(2):206-13. PubMed ID: 1905309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous luteinizing hormone surge during superovulation induction with sequential use of clomiphene citrate and pulsatile human menopausal gonadotropin.
    Messinis IE; Templeton A; Baird DT
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1076-80. PubMed ID: 3932447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clomiphene-HMG ovarian stimulation in human in vitro fertilization and embryo transfer].
    Oda T; Yoshimura S; Sumi Y; Shiina M; Yahagi M; Matsumoto C; Ohno T; Hara S; Nakamura Y; Iizuka R
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2059-66. PubMed ID: 3935741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simplification of the method of in vitro fertilization: sonographic measurements of follicular diameter as the sole index of follicular maturity.
    Nilsson L; Wikland M; Hamberger L; Hillensjö T; Chari S; Sturm G; Daume E
    J In Vitro Fert Embryo Transf; 1985 Mar; 2(1):17-22. PubMed ID: 3926921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blunted LH surge after HCG administration in cycles superovulated for in-vitro fertilization.
    Hamori M; Stuckensen JA; Rumpf D; Kniewald T; Kniewald A; Marquez M
    Hum Reprod; 1989 May; 4(4):392-5. PubMed ID: 2501335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preovulatory luteinization during induction of follicular maturation with menotrophin and menotrophin--clomiphene combination.
    Birkenfeld A; Mor-Joseph S; Ezra J; Simon A; Navot D
    Hum Reprod; 1990 Jul; 5(5):561-4. PubMed ID: 2118544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian stimulation with clomiphene and/or human menopausal gonadotropin (HMG) for in vitro fertilization (IVF) and embryo transfer (ET).
    Kemeter P; Feichtinger W
    Experientia; 1985 Dec; 41(12):1502-7. PubMed ID: 3935476
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro fertilization: diurnal and seasonal variation in luteinizing hormone surge onset and pregnancy rates.
    Casper RF; Erskine HJ; Armstrong DT; Brown SE; Daniel SA; Graves GR; Yuzpe AA
    Fertil Steril; 1988 Apr; 49(4):644-8. PubMed ID: 3127247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of various factors on in vitro fertilization (IVF) and embryo transfer in the human in clomiphene/hMG/hCG stimulated cycles].
    Baukloh V; Riedel HH; Paul S; Semm K; Mettler L
    Zentralbl Gynakol; 1985; 107(23):1409-23. PubMed ID: 3938148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined clomiphene citrate (CC) and human menopausal gonadotropins (hMG) in a fixed schedule for follicular recruitment during in vitro fertilization: effects on premature luteinizing hormone (LH) surges.
    Blankstein J; Collins RL; Easley KA; Gupta MK; Quigley MM
    J In Vitro Fert Embryo Transf; 1989 Apr; 6(2):121-4. PubMed ID: 2498445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of the LH profile in relation to ovarian stimulation regimes and embryo transfer rates in an in vitro fertilisation programme.
    Umapathysivam K; Jones WR; Meffin E
    Clin Reprod Fertil; 1986 Jun; 4(3):227-32. PubMed ID: 3091237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ovarian stimulation and corpus luteum function in human in vitro fertilization and embryo transfer].
    Hara S
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):2043-50. PubMed ID: 3123577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of the GnRH analogue buserelin for IVF--does it improve fertility?
    Shelton K; Fishel S; Jackson P; Webster J; Faratian B; Johnson J
    Br J Obstet Gynaecol; 1991 Jun; 98(6):544-9. PubMed ID: 1908314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotrophins.
    Wildt L; Diedrich K; van der Ven H; al Hasani S; Hübner H; Klasen R
    Hum Reprod; 1986 Jan; 1(1):15-9. PubMed ID: 2971082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro fertilisation. A review of drug therapy and clinical management.
    Jennings JC; Moreland K; Peterson CM
    Drugs; 1996 Sep; 52(3):313-43. PubMed ID: 8875126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination clomiphene citrate/human menopausal gonadotropin stimulation protocols for in vitro fertilization-embryo transfer.
    Hill GA; Diamond MP; Maxson WS; Herbert CM; Webster BW; Vaughn WK; Osteen KG; Rogers BJ; Wentz AC
    J In Vitro Fert Embryo Transf; 1987 Feb; 4(1):34-9. PubMed ID: 3108425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase.
    Stanger JD; Yovich JL
    Br J Obstet Gynaecol; 1985 Apr; 92(4):385-93. PubMed ID: 3921051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.